Anthony T Power - JoVE Visualize

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

Molecular Therapy : the Journal of the American Society of Gene Therapy|February 1, 2007

Cell-based delivery of oncolytic viruses: a new strategic alliance for a biological strike against cancerAnthony T Power, John C Bell

Trends in Molecular Medicine|May 4, 2004

Vesicular stomatitis virus: re-inventing the bulletBrian D Lichty, Anthony T Power, David F Stojdl, et al.

Blood|May 23, 2007

Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter geneApollina Goel, Stephanie K Carlson, Kelly L Classic, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006

Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunityAnthony T Power, Jiahu Wang, Theresa J Falls, et al.

Cancer Cell|October 31, 2003

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agentsDavid F Stojdl, Brian D Lichty, Benjamin R tenOever, et al.

Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

Molecular Therapy : the Journal of the American Society of Gene Therapy|February 1, 2007

Cell-based delivery of oncolytic viruses: a new strategic alliance for a biological strike against cancerAnthony T Power, John C Bell

Trends in Molecular Medicine|May 4, 2004

Vesicular stomatitis virus: re-inventing the bulletBrian D Lichty, Anthony T Power, David F Stojdl, et al.

Blood|May 23, 2007

Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter geneApollina Goel, Stephanie K Carlson, Kelly L Classic, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006

Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunityAnthony T Power, Jiahu Wang, Theresa J Falls, et al.

Cancer Cell|October 31, 2003

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agentsDavid F Stojdl, Brian D Lichty, Benjamin R tenOever, et al.

Pageof 1